Skip to main content
Signal8
Launch Terminal

Oaktree Acquisition Corp. III Life Sciences (OACC)

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.

Sector: Blank Checks

Industry: Shell Companies

Oaktree Acquisition Corp. II logo

Oaktree Acquisition Corp. II

NASDAQ:OACCFinancial Services
+0.19%$10.71
Mkt Cap$211.88M
Float19.78M
O/S19.78M
Inst Own89.4%
SI<0.1%
Dilution
Oaktree Acquisition Corp. II logoNASDAQ:OACC$10.71+0.19%
FormDescription
4
Statement of Changes in Beneficial Ownership
DEFA14A
Additional Proxy Materials
2
8-K
7.01
3
DEFA14A
Additional Proxy Materials
2
8-K
7.01
2
DEF 14A
Definitive Proxy Statement
6
PRE 14A
Preliminary Proxy Statement
6
13G
Beneficial Ownership Report
13G
Beneficial Ownership Report
10-Q
Quarterly Report
5
13G
Beneficial Ownership Report
10-Q
Quarterly Report
1
13G
Beneficial Ownership Report
10-K
Annual Report
13G/A
Beneficial Ownership Report (Amended)
10-Q
Quarterly Report
3
Initial Statement of Beneficial Ownership
8-K
5.02
3
Initial Statement of Beneficial Ownership
8-K
5.02
13G/A
Beneficial Ownership Report (Amended)
10-Q
Quarterly Report
13G/A
Beneficial Ownership Report (Amended)
3
Initial Statement of Beneficial Ownership
8-K
5.02

1-25 of 65